Key result
Combined NAFLD and abdominal obesity linked to ~61% greater coronary calcification risk and elevated FRS.
Why the study?
It was uncertain whether non-alcoholic fatty liver disease or abdominal obesity has stronger associations with atherosclerosis and CAD risk across different genders.
Does non-alcoholic fatty liver disease and abdominal obesity increase coronary artery calcification and Framingham risk score in Taiwanese adults?
Cross-Sectional (n=1,655)
Does non-alcoholic fatty liver disease and abdominal obesity increase coronary artery calcification and Framingham risk score in Taiwanese adults?
NAFLD is more closely associated with coronary artery calcification and higher Framingham risk score in men, whereas abdominal obesity is a stronger determinant in women.
Answers are grounded in this paper and cite their sources.
May guide sex-specific CV risk evaluation in NAFLD with abdominal obesity; hypothesis-generating pending longitudinal confirmation.
Background: It is not certain whether non-alcoholic fatty liver disease (NAFLD) or abdominal obesity (AO) has stronger associations with atherosclerosis and coronary artery disease (CAD) risk across different genders. The purpose of this study was to determine the gender-based association of NAFLD and AO with subclinical atherosclerosis represented by coronary artery calcification (CAC) and CAD risk by Framingham risk score (FRS). Methods: A total of 1,655 participants in a health-screening program (mean age: 49.44 years; males: 70.33%) were enrolled for analysis. Fatty liver and coronary artery calcium score (CACS) were measured via ultrasonography (US) and multi-detector computed tomography (MDCT). The presence of CAC was defined as having a CACS > 0, intermediate to high CAD risk was defined as FRS ≥ 10%, while the presence of AO was defined as having a waist circumference (WC) of ≥90 cm for men and ≥80 cm for women. Participants were categorized into four groups depending on the presence or absence of NAFLD and/or AO. Results: The percentage of subjects with CACS > 0 was highest in the AO-only group (overall: 42.6%; men: 48.4%; women: 35.8%); and FRS ≥ 10% was highest in the group with both abnormalities (overall: 50.3%%; men: 57.3%; women: 32.4%). After adjustment factors, the odds ratio (OR) for CAC and FRS was the highest in the group with both abnormalities [men: 1.61 (1.13-2.30) for CACS > 0 and 5.86 (3.37-10.20) for FRS ≥ 10%; women: 2.17 (1.13-4.16) for CACS > 0 and 6.31 (2.08-19.10) for FRS ≥ 10%]. In men, the OR of NAFLD was higher than that of AO [1.37 (1.03-1.83) vs. 1.35 (1.02-1.79) for CACS > 0, 3.26 (2.13-4.98) vs. 2.97 (1.91-4.62) for FRS ≥ 10%]. However, women with AO consistently showed increased OR for CACS > 0 [1.87 (1.11-3.16)] and FRS ≥ 10% [4.77 (2.01-11.34)]. Conclusion: The degree of association of NAFLD and AO with CAC and FRS depends on the gender. NAFLD is more closely associated with CACS > 0 and FRS ≥ 10% in men and AO in women, respectively. NAFLD and AO could be considered independent determinants of CAC and FRS by gender.
No takes yet. Share an insight, caveat, or question.
Tsou et al. (2022) conducted a cross-sectional in Non-alcoholic fatty liver disease and abdominal obesity (n=1,655). Non-alcoholic fatty liver disease and abdominal obesity vs. Absence of abnormalities was evaluated on Coronary artery calcification (CACS > 0) and Framingham risk score (FRS ≥ 10%) (OR 1.61, 95% CI 1.13-2.30). The combination of NAFLD and abdominal obesity was associated with the highest risk of coronary artery calcification and FRS ≥10%.
Synapse has enriched 10 related papers. Consider them for comparative context: